Search research articles
Contact Us
Filters
Showing results (201-210 of 224) with videos related to
Page
of 23
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 14, 2023
Emollients for preventing atopic eczema: Cost-effectiveness analysis of the BEEP trial
Tracey H Sach, Stella T Lartey, Charlotte Davies, et al.
Nature Communications
|
July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigens
Nichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Mbio
|
December 13, 2018
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
Lisa Bohlmann, David M P De Oliveira, Ibrahim M El-Deeb, et al.
Mbio
|
January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection
David M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
The British Journal of Dermatology
|
March 10, 2019
Conjunctivitis in dupilumab clinical trials
B Akinlade, E Guttman-Yassky, M de Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 18, 2020
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
A Wollenberg, S Christen-Zäch, A Taieb, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
Lancet (London, England)
|
September 18, 2022
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
Amy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
Health Technology Assessment (Winchester, England)
|
July 18, 2024
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, et al.
The British Journal of Dermatology
|
September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial
Carsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
Page
of 23
Search research articles
Search
Showing results (201-210 of 224) with videos related to
Sort By:
Page
of 23
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
August 14, 2023
Emollients for preventing atopic eczema: Cost-effectiveness analysis of the BEEP trial
Tracey H Sach, Stella T Lartey, Charlotte Davies, et al.
Nature Communications
|
July 1, 2025
An mRNA vaccine encoding five conserved Group A Streptococcus antigens
Nichaela Harbison-Price, Ismail Sebina, Rhiannon A Bolton, et al.
Mbio
|
December 13, 2018
Chemical Synergy between Ionophore PBT2 and Zinc Reverses Antibiotic Resistance
Lisa Bohlmann, David M P De Oliveira, Ibrahim M El-Deeb, et al.
Mbio
|
January 11, 2022
Rescuing Tetracycline Class Antibiotics for the Treatment of Multidrug-Resistant Acinetobacter baumannii Pulmonary Infection
David M P De Oliveira, Brian M Forde, Minh-Duy Phan, et al.
The British Journal of Dermatology
|
March 10, 2019
Conjunctivitis in dupilumab clinical trials
B Akinlade, E Guttman-Yassky, M de Bruin-Weller, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 18, 2020
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
A Wollenberg, S Christen-Zäch, A Taieb, et al.
The British Journal of Dermatology
|
July 24, 2024
A prospective observational cohort study comparing the treatment effectiveness and safety of ciclosporin, dupilumab and methotrexate in adult and paediatric patients with atopic dermatitis: results from the UK-Irish A-STAR register
Helen Alexander, Rayka Malek, David Prieto-Merino, et al.
Lancet (London, England)
|
September 18, 2022
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial
Amy S Paller, Eric L Simpson, Elaine C Siegfried, et al.
Health Technology Assessment (Winchester, England)
|
July 18, 2024
Emollient application from birth to prevent eczema in high-risk children: the BEEP RCT
Lucy E Bradshaw, Laura A Wyatt, Sara J Brown, et al.
The British Journal of Dermatology
|
September 18, 2023
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial
Carsten Flohr, Anna Rosala-Hallas, Ashley P Jones, et al.
Page
of 23